News & Updates

Show Multimedia Only

Antidepressant use among HCC patients linked to lower risk of death

22 Sep 2023

For patients with hepatocellular carcinoma (HCC), the use of antidepressants after diagnosis may signal increased overall and cancer-specific survival, according to a study.

22 Sep 2023

Liver transplant confers better long-term survival in select CRC patients

19 Sep 2023

In the treatment of patients with nonresectable colorectal cancer (CRC) with liver metastases, liver transplantation may improve long-term survival outcomes especially when performed for those with favourable prognostic scoring, according to a study.

19 Sep 2023

Bulevirtide boasts high barrier to resistance for chronic hepatitis delta

13 Sep 2023

A recent study has found no amino acid substitutions associated with reduced sensitivity to bulevirtide (BLV) monotherapy, a hepatitis D/B virus (HDV/HBV) entry inhibitor, at baseline or week 24 in patients with virologic breakthrough after BLV treatment.

13 Sep 2023

Noninvasive MRE accurately stages liver fibrosis in NAFLD

13 Sep 2023 by

Magnetic resonance elastography demonstrates high accuracy in the noninvasive staging of liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD), reports a study.

13 Sep 2023

HIMALAYA: Long-term OS benefit with STRIDE regimen in uHCC

07 Sep 2023 by

Treatment with tremelimumab plus durvalumab (STRIDE* regimen) continues to yield overall survival (OS) benefit at 4 years among patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib, according to the updated results of the HIMALAYA trial presented at ESMO WCGIC 2023.

07 Sep 2023

Early cholecystectomy must be carefully considered in acute biliary pancreatitis

26 Aug 2023

Older and more fragile patients who present with severe complications associated with acute biliary pancreatitis (ABP) may not be the best candidates for early cholecystectomy, real-life data from the MANCTRA-1* study.

26 Aug 2023

Intra-arterial gemcitabine bumps up survival in locally advanced pancreatic cancer

25 Aug 2023 by

In patients with locally advanced pancreatic cancer, treatment with intra-arterial gemcitabine leads to better survival and safety outcomes compared with standard-of-care therapy with intravenous gemcitabine/nab-paclitaxel, according to the first interim analysis of the phase III TIGeR-PaC trial presented at ESMO GI 2023.

25 Aug 2023

HILPDA induces development of NASH-driven HCC

12 Aug 2023

Hepatic hypoxia-inducible lipid droplet associated protein (HILPDA) is predictive of survival in patients with nonalcoholic steatohepatitis (NASH)-driven hepatocellular carcinoma (HCC), according to a study.

12 Aug 2023

Global NAFLD incidence on the rise

11 Aug 2023

Current estimates of nonalcoholic fatty liver disease (NAFLD) incidence across the world show an increasing trend, with 4,613 new cases per 100,000 person-years, reveals a study.

11 Aug 2023

Minimal monitoring feasible in HCV patients on SOF/VEL

26 Jul 2023 by

Minimal monitoring is feasible in patients with active hepatitis C virus (HCV) infection treated with sofosbuvir/velpatasvir (SOF/VEL), with high rates of sustained virologic response (SVR) reported, including in patients with novel HCV subtypes, according to new data from the phase IV MINMON study presented at IDDF 2023.

26 Jul 2023

News & Updates

Showing Hepatology articles

Showing

Specialty:

Antidepressant use among HCC patients linked to lower risk of death

Liver transplant confers better long-term survival in select CRC patients

Bulevirtide boasts high barrier to resistance for chronic hepatitis delta

Noninvasive MRE accurately stages liver fibrosis in NAFLD

HIMALAYA: Long-term OS benefit with STRIDE regimen in uHCC

Early cholecystectomy must be carefully considered in acute biliary pancreatitis

Intra-arterial gemcitabine bumps up survival in locally advanced pancreatic cancer

HILPDA induces development of NASH-driven HCC

Global NAFLD incidence on the rise

Minimal monitoring feasible in HCV patients on SOF/VEL